Robert Hershberg - Feb 4, 2025 Form 4 Insider Report for HilleVax, Inc. (HLVX)

Role
President and Chief Executive Officer, Director
Signature
/s/ Paul Bavier, Attorney-in-Fact for Robert Hershberg
Stock symbol
HLVX
Transactions as of
Feb 4, 2025
Transactions value $
-$48,661
Form type
4
Date filed
2/12/2025, 04:05 PM
Previous filing
Jun 5, 2024
Next filing
Mar 6, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HLVX Common Stock Sale -$27.7K -14.6K -1.3% $1.89 1.11M Feb 4, 2025 Direct F1
transaction HLVX Common Stock Sale -$21K -11.9K -1.07% $1.76 1.1M Feb 11, 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1. Represents shares sold to satisfy tax withholding obligations upon the settlement of restricted stock units ("RSUs"), which sale was mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
F2 2. The price reported in Column 4 is the weighted average price. These shares were sold in multiple transactions at prices between $1.7551 and $1.7745. The Reporting Person undertakes to provide the Issuer, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Remarks:

President and Chief Executive Officer